Current Portfolio
Acrux use in-house capabilities to develop and commercialise pharmaceutical products for global markets
Develops, manufactures and supplies digital health technologies
Developing novel drugs for inflamatory and immune diseases
Canary Medical Inc. develops medical implant and data management devices
Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™
Humanetix software automates administration through work-flow, giving users more time and energy for their most important tasks
Identifying disease through transcriptomics and mutation detection
Pharmamark is a leader in innovative microencapsulated lipids and bioactives for infant formula, ba foods, maternal and adult nutrition, and food and beverage fortification.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report
Provider Assist (PA) is the end-to-end partner for Aged Care and Support at Home providers in delivering integrated clinical, business, and digital expertise.
Pioneer of the REX Robot that enhances the mobility of wheelchair users
Closed loop neuromodulation technology to record and measure electrical nerve signals
Manufacturer of high quality fish oils (omega-3 and omega-2)
Exited Portfolio
Biopharmaceutical company with a technology that improves the delivery of anti-cancer drugs
Focused on the development of bacteriophage for the treatment of bacterial infection
Protein engineering technology platform to transform proteins into potent drug candidates
Regenerative products for the treatment of a broad range of wounds, scars and skin defects.
Biotechnology company focused on developing topical dermatological treatments for pre-cancerous skin lesions.
Now known as Aviragen Therapeutics, Inc. focused on the development of direct-acting antivirals
Focus on investigational & psychotropic medicines, healthcare technology, and novel consumer health products
Develops and manufactures miniaturised implantable heart pumps, or ventricular assist devices, to treat advanced heart failure
Developing therapies for neurological disorders
PETization™ technology to develop novel biologic therapies for companion animals
Biotechnology company focused on developing topical dermatological treatments for pre-cancerous skin lesions.
Pharmaceutical research company discovering drugs that treat the burden of long-term heart disease
© BioScience Managers, all rights reserved